JAGX

← Markets

JAGXJaguar Health, Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Wed, Aug 26
8:00 AMstocktitan.netCommercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Thu, Aug 20
12:02 AMYahooJaguar Health Inc (JAGX) (Q2 2026) Earnings Call Highlights: Rare Disease Breakthroughs and ...
Wed, Aug 19
3:00 PMstocktitan.netJaguar Health Reports Second Quarter 2026 Financials
Tue, Aug 18
8:00 AMYahooJaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates
Wed, Aug 5
8:00 AMYahooJaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
Tue, Jul 28
8:00 AMYahooJaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
Wed, Jul 22
8:00 AMYahooAdditional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Tue, Jun 30
8:00 AMYahooPresentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Thu, Jun 25
8:00 AMYahooJaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
Tue, Jun 23
8:00 AMYahooJaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Mon, Jun 22
8:00 AMYahooJaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Thu, Jun 18
8:00 AMYahooMagdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention